Bharat Biotech sets up CRDMO arm to focus on cell and gene therapies

[ad_1] Bharat Biotech launches Nucelion Therapeutics, a CRDMO focused on advanced cell and gene therapies for global life science innovators. File Vaccine maker Bharat Biotech has established a contract research development and manufacturing organisation (CRDMO) focused on cell and gene therapies. Setting up of the wholly-owned subsidiary Nucelion Therapeutics is part of a strategic expansion […]

Continue Reading

Bharat Biotech’s intranasal COVID-19 vaccine to cost ₹800 for private markets

[ad_1] Image for representational purposes only. | Photo Credit: The Hindu Hyderabad-based Bharath Biotech said Tuesday that its nasally administered vaccine, iNCOVACC, would be available for public use from the fourth week of January and cost ₹800 for private markets and ₹325 for governments.  iNCOVACC will be rolled out as a booster dose for those […]

Continue Reading